Effects of Electrical Stimulation for Preventing Loss of Muscle Mass in Patients With SIRS, Sepsis and Septic Shock
NCT ID: NCT03754257
Last Updated: 2024-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2018-10-01
2024-10-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To evaluate the effects of electrical stimulation in the prevention of muscle mass loss in patients admitted to the ICU with systemic inflammatory response syndrome (SIRS), sepsis or septic shock.
Methods: This is a randomized, controlled, double-blind clinical trial. Thirty-six patients with a diagnosis of SIRS, sepsis or septic shock (including patients with sepsis due to the new coronavirus - COVID-19) will be randomly assigned to experimental group and sham group. They will be evaluated in relation to muscle mass, peripheral muscle strength and functional status. They will also be submitted to the collection of inflammatory, metabolic, damage and muscular trophism markers.
Expected results: Electrical stimulation is expected to be able to prevent loss of muscle mass in patients admitted to the ICU with SIRS, sepsis or septic shock. In addition, it is expected to be able to preserve strength in this population without increasing the pro-inflammatory or metabolic response.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrical Muscle Stimulation in the Development of Acquired Weakness in Patients With Severe Sepsis and Septic Shock
NCT03765489
Neuromuscular Electrical Stimulation and Septic Shock
NCT03193164
Rehabilitation of Critically Ill Patients With SARS-CoV-2 Variants in ICU With Limited Resources
NCT05450120
Effect of Different Electric Muscle Stimulation in Patients With Severe Sepsis and Respiratory Failure
NCT01895647
Electrical Stimulation of the Quadriceps and Diaphragm in Critically Ill Patients
NCT03352102
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Electrical Stimulation
Experimental Electrical Stimulation for 40 minutos + conventional physiotherapy, during seven days.
Experimental Electrical Stimulation
Experimental Electrical Stimulation (100Hz) during 40 minutes
Conventional Physiotherapy
Active and passive exercises, and walking.
Sham Electrical Stimulation
Sham Electrical Stimulation for 40 minutes + conventional physiotherapy, during seven days.
Sham Electrical Stimulation
Sham Electrical Stimulation (5Hz) during 40 minutes
Conventional Physiotherapy
Active and passive exercises, and walking.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental Electrical Stimulation
Experimental Electrical Stimulation (100Hz) during 40 minutes
Sham Electrical Stimulation
Sham Electrical Stimulation (5Hz) during 40 minutes
Conventional Physiotherapy
Active and passive exercises, and walking.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged ≥ 18 years,
* body mass index (BMI) ≤ 35 kg / m2,
* without diabetic polyneuropathy,
* without cardiac pacemaker,
* without diagnosis of neuromuscular diseases,
* absence of skin lesions.
Exclusion Criteria
* death.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Sirio-Libanes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wellington Yamaguti
Wellington Pereira dos Santos Yamaguti
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Sírio-Libanês
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3.999.139
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.